Novel HTK-AD effective in preventing postsurgical hair shedding among patients undergoing hair transplantation
China: The novel histidine-tryptophan-ketoglutarate solution with adenosine triphosphate and deferoxamine (HTK-AD) is superior to the conventional Ringer solution (RS) for hair graft preservation in hair transplantation needing long operative time, a randomized controlled trial has shown.
"The novel HTK-AD solution, compared to the Ringer solution, improved graft viability and prevented transient postsurgical hair shedding," researchers report in their study published in Dermatologic Surgery.
Live/dead staining showed greater cell viability in grafts stored in HTK-AD than in RS. Procedures using HTK-AD had a remarkably reduced incidence of postoperative hair shedding, decreased maximal percentage of shedding, and delayed shedding onset compared with the RS procedures.
Hair transplantation has gained popularity for treating alopecia. However, postsurgical hair shedding remains concerning for both patients and surgeons. Yong Miao, Nanfang Hospital of Southern Medical University Guangzhou, Guangdong Province, China, and colleagues, therefore, aimed to investigate the impact of the graft-holding solution on postsurgical hair shedding and testify to the protective efficacy of histidine-tryptophan-ketoglutarate solution with adenosine triphosphate and deferoxamine (HTK-AD).
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.